Maywufa Co., Ltd. (1731) AI Stock Analysis

Maywufa Co., Ltd.

(TWSE:1731)

Select Model

Rating:71Outperform

Price Target:TWD 23.00▲(10.58% Upside)

Action:initiatedcoverage

Date:11/10/26

The score is primarily supported by solid financial strength and attractive valuation, while weak-to-neutral technical momentum reduces the overall result. The weighted average is 70.8, rounded to 71.

Positive Factors

Steady Revenue GrowthThe company has maintained a positive revenue trajectory across several years, indicating sustained demand for its textile and apparel materials. Although growth moderated in 2025, continued expansion provides a durable base for utilization, customer retention, and future profitability.

Negative Factors

Volatile Free Cash FlowThe sharp variation in free cash flow indicates that reported earnings have not translated consistently into discretionary cash generation. Even with the strong 2025 rebound, this history can complicate reinvestment, dividends, and balance-sheet planning if volatility returns.

Maywufa Co., Ltd. (1731) vs. SPDR S&P 500 ETF (SPY)

Market Cap: TWD 2.84B
Dividend Yield: 5.87%
Average Volume (3M): 99.42K
Price to Earnings (P/E): 13.8
Beta (1Y): 0.13
Revenue Growth: 7.65%
EPS Growth: 15.75%
Country: TW
Employees: 282
Sector: General
Sector Strength: 55
Industry: Household & Personal Products

Maywufa Co., Ltd. Business Overview & Revenue Model

Company Description

Maywufa Company Ltd. manufactures and sells hair and skin care products under the Maywufa brand in Taiwan. The company engages in the manufacturing, processing, and distribution of hairdressing products, soap, and cosmetics; distribution, wholesale,...

Maywufa Co., Ltd. Financial Statement Overview

Summary

Financially sound overall, supported by strong profitability, substantial equity, manageable debt, and positive 2025 free cash flow. The score is limited by declining margins, moderate return on equity, and volatile cash flow.

Income Statement

78Positive

Balance Sheet

84Very Positive

Cash Flow

72Positive

Financial statement breakdown
Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	1.64B	1.58B	1.49B	1.30B	1.25B	1.29B
Gross Profit	997.29M	1.00B	961.75M	854.37M	816.56M	859.44M
EBITDA	258.44M	271.75M	258.65M	239.13M	239.54M	248.12M
Net Income	201.32M	181.00M	173.23M	169.10M	161.83M	164.32M
Balance Sheet
Total Assets	3.48B	3.24B	3.18B	2.83B	2.53B	2.69B
Cash, Cash Equivalents and Short-Term Investments	755.38M	620.06M	605.49M	573.61M	584.38M	879.67M
Total Debt	640.73M	641.77M	673.80M	442.67M	227.00M	317.16M
Total Liabilities	1.29B	1.07B	1.07B	794.91M	532.92M	686.54M
Stockholders Equity	2.19B	2.16B	2.11B	2.04B	2.00B	2.01B
Cash Flow
Free Cash Flow	330.26M	210.60M	-58.09M	-9.81M	-82.51M	257.36M
Operating Cash Flow	343.95M	227.85M	215.69M	244.32M	147.88M	262.98M
Investing Cash Flow	-7.90M	5.20M	-283.93M	-308.39M	36.20M	-210.95M
Financing Cash Flow	-161.65M	-196.48M	62.35M	66.52M	-245.54M	-140.29M

Maywufa Co., Ltd. Peers Comparison

Overall Rating

UnderperformOutperform

Sector (55)

Financial Indicators

TW:1731 against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
TW:1780	71Outperform	TWD 2.59B	8.03	―	5.27%	―	―
TW:1731	71Outperform	TWD 2.77B	13.77	―	5.87%	7.65%	15.75%
TW:1752	65Neutral	TWD 3.02B	16.07	―	5.35%	-6.10%	-26.89%
TW:1733	63Neutral	TWD 2.85B	15.05	―	4.55%	-5.22%	22.94%
Sector *	55Neutral	$6.65B	3.83	-15.92%	6.20%	10.91%	7.18%
TW:8433	52Neutral	TWD 2.68B	7.66	―	8.55%	9.23%	66.23%
TW:6504	41Neutral	TWD 2.58B	-547.06	―	2.69%	-1.43%	92.88%

* General Sector Average

Performance Comparison

TW:1731 and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
TW:1731	Maywufa Co., Ltd.	20.80	-0.02	-0.08%
TW:1733	Apex Biotechnology Corp.	28.60	-1.34	-4.47%
TW:1752	Nang Kuang Pharmaceutical Co., Ltd.	29.90	-6.84	-18.62%
TW:1780	Allied Biotech Corp	23.70	6.00	33.88%
TW:6504	Nan Liu Enterprise Co., Ltd	37.20	-4.91	-11.66%
TW:8433	Bon Fame Co., Ltd.	49.15	-0.50	-1.00%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 09, 2026

Maywufa Co., Ltd. AI Stock Analysis